{"entity":{"id":"nct02464332","kind":"trial","name":"Safety Study of BLZ-100 in Adult Subjects With Sarcoma Undergoing Surgery","aka":[],"tldr":"A phase 1 trial of Tozuleristide run by Blaze Bioscience Inc., withdrawn before enrolling.","summary":"Safety Study of BLZ-100 in Adult Subjects With Sarcoma Undergoing Surgery is a phase 1 interventional study registered as NCT02464332 by Blaze Bioscience Inc., started 2015-09. Conditions recorded: Sarcoma, Soft Tissue. Interventions recorded: BLZ-100.","status":"withdrawn","asOf":"2026-11-03","links":[{"label":"ClinicalTrials.gov NCT02464332","url":"https://clinicaltrials.gov/study/NCT02464332"}],"tags":["pipeline","ctgov-ingest"],"related":[],"cancers":["sarcoma"],"sections":[],"technologies":[],"targets":[],"drugs":["blz-100"],"companies":["blaze-bioscience"],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT02464332","phase":"1","setting":"A Phase 1 Study of BLZ-100 Administered by Intravenous Injection in Subjects With Soft Tissue Sarcoma Undergoing Surgery","sponsor":"Blaze Bioscience Inc.","enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct02464332/","neighbours":{"cancer":[{"id":"sarcoma","kind":"cancer","name":"Sarcomas (soft tissue, bone, GIST)","route":"/cancers/sarcoma/"}],"drug":[{"id":"blz-100","kind":"drug","name":"Tozuleristide","route":"/drugs/blz-100/"}],"company":[{"id":"blaze-bioscience","kind":"company","name":"Blaze Bioscience","route":"/companies/blaze-bioscience/"}]}}